Early Access

10-QPeriod: Q3 FY2014

CME GROUP INC. Quarterly Report for Q3 Ended Sep 30, 2014

Filed November 3, 2014For Securities:CME

Summary

CME Group Inc. reported strong revenue growth for the third quarter of 2014, driven primarily by a significant increase in clearing and transaction fees, up 7% year-over-year. This surge was fueled by a 12% rise in total contract volume, particularly in interest rate and equity products, despite a slight decline in the average rate per contract. Market data and information services also saw robust growth of 12%. While operating expenses increased, the company maintained a healthy operating margin of 56.5%, reflecting effective cost management. Net income attributable to CME Group rose 23% to $290.0 million, with diluted earnings per share increasing to $0.86. The company's balance sheet remains robust, with substantial liquidity and manageable debt levels, reinforced by strong credit ratings. The nine-month performance also showed positive trends, with total revenues up 1% to $2.27 billion and net income up 5% to $820.6 million. While overall contract volume saw a modest increase, a decline in the average rate per contract was noted, impacting the total clearing and transaction fees year-over-year. Despite these nuances, CME Group demonstrates a solid financial position, supported by its diversified revenue streams and strategic initiatives, including the integration of new regulations and ongoing product development.

Financial Statements
Beta
Revenue$762.40M
Operating Expenses$332.00M
Operating Income$430.40M
Net Income$290.00M
EPS (Basic)$0.87
EPS (Diluted)$0.86
Shares Outstanding (Basic)334.42M
Shares Outstanding (Diluted)336.17M

Key Highlights

  • 1Total revenues increased by 7% to $762.4 million in Q3 2014 compared to Q3 2013.
  • 2Clearing and transaction fees grew by 7% to $641.8 million in Q3 2014, driven by a 12% increase in total contract volume.
  • 3Interest rate product volume saw a significant increase of 23% in Q3 2014, indicating strong demand in this segment.
  • 4Net income attributable to CME Group increased by 23% to $290.0 million in Q3 2014.
  • 5Diluted earnings per share improved to $0.86 in Q3 2014, up from $0.71 in Q3 2013.
  • 6The company maintained strong operating margins, with an operating margin of 56.5% in Q3 2014.
  • 7Cash flow from operating activities decreased by 12% for the nine months ended September 30, 2014, compared to the prior year, primarily due to higher bonus payments and legal expenses.

Frequently Asked Questions